XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
NOTE 8 - RELATED PARTY TRANSACTIONS
3 Months Ended
Jul. 31, 2022
Notes  
NOTE 8 - RELATED PARTY TRANSACTIONS

NOTE 8 - RELATED PARTY TRANSACTIONS

 

Related parties of the Company consist of the followings

 

-Mr. Weidong Chai, a legal representative of Qufu Natural Green; 

-Shandong Shengwang Pharmaceutical Co., Ltd. ("Pharmaceutical Corporation"), a Chinese limited liability company of which Mr. Chai is the Chairman; 

-Mr. Laiwang Zhang, former Chairman of the Board of the Company, resigned on September 7, 2021; and 

-Qufu Shengwang Import and Export Co., Ltd. ("Qufu Shengwang Import and Export"), a Chinese limited liability company, controlled by Mr. Laiwang Zhang. Due to recent changes in management personnel, Qufu Shengwang Import and Export is no longer considered a related party, and transactions with Qufu Shengwang Import and Export have been reclassified to third party transactions in fiscal 2022. 

 

Revenue - related party

 

For the three months ended July 31, 2022 we did not have revenue and cost of revenue from related party, but we recorded revenue - related party and cost of revenue – related party of $2,386,628 and $2,617,569 the three months ended July 31, 2021, respectively, from Qufu Shengwang Import and Export.

 

Due to related parties

 

The Company mainly finances its operations through proceeds borrowed from related parties. As of July 31, 2022 and April 30, 2022, due to related parties consisted the following:

 

July 31,
2022

April 30,
2022

Pharmaceutical Corporation

$4,542,438 

$4,646,092 

Weidong Chai

238,610 

236,070 

Total

$4,781,048 

$4,882,162 

 

On September 23, 2019, the Company borrowed a one-year loan of RMB1,221,000 (approximately $189,000) from Weidong Cai, bearing an annual interest rate of 10%. On September 23, 2021 and 2020, the parties extended the loan for another year, under the same terms and conditions, reclassified unpaid interest payable to the principal of this loan, resulting in an increase of principal from RMB1,221,000 (approximately $189,000) to RMB1,477,410 (approximately $224,000).